Anti-CD20 Therapies in Pediatric Acquired Demyelinating Syndromes: Evidence Across MS, AQP4-IgG-Positive NMOSD and MOGAD. - Margoni M; Preziosa P; Rocca MA; Filippi M (CNS drugs, 2026)